states

Pharmalot By Ed Silverman

A nascent state effort would tax drug makers for not providing clinical evidence for price hikes

Politics By Rachel Cohrs

Andrew Cuomo’s Covid-19 nursing home fiasco shows the ethical perils of pandemic policymaking

Politics By Lev Facher

States still can’t import drugs from Canada. Now, many are seeking to import Canadian prices

Health By Amy Sokolow

A Baltimore pastor, preaching about vaccines to the Black community, emphasizes personal agency

First Opinion By Eli Cahan

A new rule that protects VA clinicians who practice across state lines should kick off a movement

First Opinion By Amy K. Liebman

Every state needs emergency regulations to protect essential food workers

Health By Andrew Joseph

‘They’re not really doing anything’: As Covid-19 cases spiral, leaders around the U.S. lose urgency on prevention

Politics By Andrew Joseph, Lev Facher, Kate Sheridan, and Nicholas Florko

Shalala loses — and other 2020 election results that will have big implications for health and science

First Opinion By Kacie Kidd and Gina Sequeira

Laws to ban gender-affirming care could increase youth suicides, parents fear

Politics By Usha Lee McFarling

With wildfires burning and Covid-19 spreading, can California afford stem cell research? Voters are set to decide

Special Report By Lev Facher

First-of-its-kind examination shows how widely pharma showers campaign cash at the state level

Politics By Nicholas Florko

Drug makers sue to block Minnesota law making it cheaper to get insulin in emergencies

Pharmalot By Ed Silverman

Maryland governor vetoes funding for a prescription drug affordability board

Politics By Nicholas Florko

After a hard-won political fight, this state expanded access to insulin. Can others follow its lead?

Politics By Lev Facher

Trump outlines ‘phases’ for reopening states once coronavirus cases begin to decline

Politics By Nicholas Florko

State legislatures are lapping the federal government on drug pricing — even amid the coronavirus

Politics By Lev Facher

‘Reject Big Pharma’: Anti-vaccine activists co-opt a populist slogan to try to repeal a state immunization law

Pharmalot By Ed Silverman

Americans with employer coverage saw growth in drug spending outpace other medical costs

Pharmalot By Ed Silverman

PBMs favor their own pharmacies in the Florida Medicaid program

Pharmalot By Ed Silverman

Bristol-Myers and Sanofi accuse Hawaii of violating their free speech rights

Pharmalot By Ed Silverman

California plans to sell its own generic drugs in hopes of lowering costs

Health By Andrew Joseph and Shraddha Chakradhar

Faced with prescriber fears of OxyContin misuse, Purdue sales reps misleadingly played up drug’s safety, documents show

Pharmalot By Ed Silverman

Florida becomes the latest state to examine Sun Pharma licenses for distributing samples

Pharmalot By Ed Silverman

Generic makers will appeal ruling that allows California to proceed with law banning pay-to-delay deals

Politics By Nicholas Florko

3 drug pricing policy experiments to watch in 2020